Arrow Lab Solutions Opens World’s First Dedicated Microplastics Research Lab

February 24, 2025 08:09 PM GMT | By EIN Presswire
 Arrow Lab Solutions Opens World’s First Dedicated Microplastics Research Lab
Image source: EIN Presswire

Arrow Lab Solutions, the company behind Plastictox, has announced the construction of the world’s first lab dedicated exclusively to microplastics research. MI, UNITED STATES, February 24, 2025 /EINPresswire.com/ -- Already the holder of the largest body of data concerning microplastics in human samples, Arrow is building the first and only lab dedicated exclusively to microplastic research. This lab is currently being built in the US, with assistance from our partners at SV Biotech in The Netherlands. The first of its kind, this lab promises to act as a global center for all research in the realm of microplastics and their effects on the human body.

Serving as the primary hub for research and development in the field of microplastics, Arrow has already landed several research contracts for this new lab. Utilizing their proprietary blend of dyes, solvents, and acids coupled with cutting edge advancements in fluorescent microscopy, the Plastictox method has been and is being adapted for myriad sample types. A Q2-Q3 planned release of oral fluid and semen testing is currently being developed with expansion into organ biopsy and fluid testing also being planned to meet the needs of many large research clinics. Having detected microplastics in over 90% of the thousands of individuals studied, Arrow is dedicated to furthering these studies.

The lab construction itself, housed inside the kit assembly plant, is designed to be plastic free from the ground-up. Utilizing stainless steel for all surfaces and plastic free rubber flooring, risk of any contamination has been nullified. A lab that exclusively focuses on microplastics and their effects on human health will prove to be a game changer for clinicians and research institutions alike. While Arrow Lab Solutions has done more research in the field of microplastics than any other institution, having a lab dedicated to this purpose will allow unprecedented scaling in this new and exciting field of study. With publications on the horizon and more being planned, the world finally has a place to go to for answers to the questions surrounding microplastics and their effects on human health.

Arrow also pledges to utilize partnerships with our newly founded sister corporations, Plastictox EU and Plastictox UK, to expand our coverage ability and ensure that Plastictox and other research ventures are truly accessible throughout the world.

Alan Morrison
Arrow Lab Solutions
[email protected]
Visit us on social media:
X
LinkedIn
Instagram

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next